Mar
23
Bayer, Curadev ink pact to discover drug candidates for lung, cardiovascular, inflammatory diseases
Posted by
www.biotecnika.org
Global pharma and life sciences major Bayer and domestic drug
discovery firm Curadev have signed a research collaboration and
licence agreement to discover new drug candidates for treatment of
lung, cardiovascular and inflammatory diseases.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bayer-curadev-ink-pact-to-discover-drug-candidates-for-lung-cardiovascular-inflammatory-diseases/articleshow/74775451.cms
Subscribe to:
Post Comments (Atom)
Post a Comment